Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Candida albicans | 25 | 2021 | 164 | 5.150 |
Why?
|
| Candidiasis | 15 | 2018 | 84 | 2.450 |
Why?
|
| Fungal Proteins | 12 | 2021 | 140 | 2.450 |
Why?
|
| Hyphae | 15 | 2021 | 36 | 2.290 |
Why?
|
| Gene Expression Regulation, Fungal | 9 | 2021 | 74 | 1.330 |
Why?
|
| Repressor Proteins | 6 | 2016 | 249 | 1.030 |
Why?
|
| Antifungal Agents | 8 | 2019 | 148 | 1.020 |
Why?
|
| Biofilms | 9 | 2019 | 168 | 0.830 |
Why?
|
| Neuregulin-1 | 3 | 2016 | 23 | 0.820 |
Why?
|
| Virulence | 12 | 2019 | 223 | 0.690 |
Why?
|
| Mice, Inbred BALB C | 8 | 2017 | 661 | 0.490 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 1371 | 0.450 |
Why?
|
| Genetic Engineering | 3 | 2007 | 33 | 0.430 |
Why?
|
| GATA Transcription Factors | 1 | 2012 | 2 | 0.430 |
Why?
|
| Extracellular Matrix | 2 | 2019 | 115 | 0.420 |
Why?
|
| Fungal Vaccines | 2 | 2009 | 41 | 0.390 |
Why?
|
| Mice | 14 | 2017 | 5913 | 0.390 |
Why?
|
| Doxycycline | 3 | 2011 | 30 | 0.360 |
Why?
|
| DNA-Binding Proteins | 4 | 2010 | 539 | 0.350 |
Why?
|
| Stress, Physiological | 2 | 2012 | 150 | 0.350 |
Why?
|
| Genome, Fungal | 2 | 2019 | 22 | 0.310 |
Why?
|
| Animals | 17 | 2017 | 15081 | 0.270 |
Why?
|
| Mycoses | 1 | 2005 | 30 | 0.260 |
Why?
|
| Yeasts | 1 | 2003 | 19 | 0.230 |
Why?
|
| Kidney | 5 | 2011 | 337 | 0.220 |
Why?
|
| Membrane Proteins | 1 | 2006 | 517 | 0.210 |
Why?
|
| Endothelial Cells | 3 | 2011 | 308 | 0.210 |
Why?
|
| Transcription Factors | 2 | 2006 | 681 | 0.200 |
Why?
|
| Lactams, Macrocyclic | 1 | 2021 | 8 | 0.190 |
Why?
|
| Benzoquinones | 1 | 2021 | 36 | 0.190 |
Why?
|
| Small Molecule Libraries | 2 | 2017 | 45 | 0.180 |
Why?
|
| Streptococcus gordonii | 1 | 2019 | 2 | 0.170 |
Why?
|
| Proteomics | 3 | 2006 | 325 | 0.170 |
Why?
|
| Microbial Interactions | 1 | 2019 | 10 | 0.170 |
Why?
|
| Gene Expression | 2 | 2012 | 674 | 0.160 |
Why?
|
| Female | 11 | 2017 | 20969 | 0.150 |
Why?
|
| Amides | 1 | 2018 | 68 | 0.150 |
Why?
|
| Benzamides | 1 | 2017 | 78 | 0.150 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 626 | 0.130 |
Why?
|
| Cell Adhesion | 2 | 2019 | 212 | 0.130 |
Why?
|
| Candida | 2 | 2006 | 40 | 0.130 |
Why?
|
| Drug Discovery | 1 | 2016 | 82 | 0.130 |
Why?
|
| Virulence Factors | 4 | 2019 | 113 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 65 | 0.110 |
Why?
|
| Culture Media | 2 | 2010 | 90 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2014 | 201 | 0.110 |
Why?
|
| RNA Stability | 1 | 2012 | 26 | 0.110 |
Why?
|
| Open Reading Frames | 1 | 2012 | 77 | 0.100 |
Why?
|
| Humans | 14 | 2019 | 37093 | 0.100 |
Why?
|
| Actins | 2 | 2003 | 148 | 0.100 |
Why?
|
| Tetracycline | 1 | 2011 | 17 | 0.100 |
Why?
|
| Candidiasis, Oral | 1 | 2011 | 23 | 0.100 |
Why?
|
| Mouth Mucosa | 1 | 2011 | 34 | 0.100 |
Why?
|
| Mutation | 5 | 2011 | 1095 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 2 | 2011 | 186 | 0.090 |
Why?
|
| Tissue Engineering | 1 | 2011 | 60 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2011 | 166 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 2003 | 305 | 0.090 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2006 | 78 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 578 | 0.090 |
Why?
|
| Nitrogen | 1 | 2010 | 71 | 0.080 |
Why?
|
| Oxygen | 1 | 2010 | 207 | 0.080 |
Why?
|
| Vaccines, Synthetic | 1 | 2009 | 72 | 0.080 |
Why?
|
| Vaccines, Attenuated | 1 | 2009 | 72 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 286 | 0.080 |
Why?
|
| Spleen | 2 | 2011 | 199 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2009 | 325 | 0.080 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 71 | 0.080 |
Why?
|
| Mice, SCID | 1 | 2007 | 150 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2007 | 84 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1039 | 0.070 |
Why?
|
| Fluconazole | 2 | 2006 | 41 | 0.070 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2006 | 1 | 0.070 |
Why?
|
| Mice, Nude | 1 | 2007 | 337 | 0.070 |
Why?
|
| Antigens, Fungal | 1 | 2006 | 31 | 0.070 |
Why?
|
| Tenascin | 1 | 2006 | 6 | 0.070 |
Why?
|
| Family Health | 1 | 2006 | 56 | 0.070 |
Why?
|
| Fibrinogen | 1 | 2006 | 23 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 515 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 357 | 0.070 |
Why?
|
| DNA, Fungal | 1 | 2005 | 46 | 0.070 |
Why?
|
| Laminin | 1 | 2006 | 61 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 118 | 0.070 |
Why?
|
| Fibronectins | 1 | 2006 | 66 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2017 | 112 | 0.070 |
Why?
|
| Mutagenesis | 1 | 2005 | 89 | 0.070 |
Why?
|
| Time Factors | 2 | 2007 | 1742 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 306 | 0.060 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 180 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 2 | 2003 | 105 | 0.060 |
Why?
|
| Cell Surface Extensions | 1 | 2003 | 7 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 26 | 0.060 |
Why?
|
| Pharyngitis | 1 | 2003 | 2 | 0.060 |
Why?
|
| Abnormalities, Radiation-Induced | 1 | 2003 | 3 | 0.060 |
Why?
|
| Candida glabrata | 1 | 2003 | 5 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2019 | 513 | 0.060 |
Why?
|
| Farnesol | 1 | 2002 | 4 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 307 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 1609 | 0.050 |
Why?
|
| Survival Rate | 1 | 2003 | 311 | 0.050 |
Why?
|
| Pseudopodia | 1 | 2001 | 15 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2003 | 381 | 0.050 |
Why?
|
| Mouth | 1 | 2019 | 45 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2001 | 360 | 0.040 |
Why?
|
| Heart-Lung Machine | 1 | 1998 | 1 | 0.040 |
Why?
|
| Diuretics, Osmotic | 1 | 1998 | 5 | 0.040 |
Why?
|
| Diuresis | 1 | 1998 | 7 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2018 | 37 | 0.040 |
Why?
|
| Mannitol | 1 | 1998 | 11 | 0.040 |
Why?
|
| Saliva | 1 | 2019 | 107 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1998 | 23 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2018 | 177 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2019 | 435 | 0.040 |
Why?
|
| Cytokines | 2 | 2011 | 602 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2018 | 399 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 352 | 0.030 |
Why?
|
| Brain | 1 | 2003 | 1346 | 0.030 |
Why?
|
| Drug Resistance, Fungal | 2 | 2006 | 32 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 864 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 2012 | 69 | 0.030 |
Why?
|
| Cell Line | 2 | 2009 | 1354 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 1908 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2011 | 21 | 0.020 |
Why?
|
| Triazoles | 1 | 2012 | 86 | 0.020 |
Why?
|
| beta-Defensins | 1 | 2011 | 4 | 0.020 |
Why?
|
| Response Elements | 1 | 2011 | 56 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2011 | 66 | 0.020 |
Why?
|
| Chemokines | 1 | 2011 | 97 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1991 | 120 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 267 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 218 | 0.020 |
Why?
|
| Adhesiveness | 1 | 2009 | 5 | 0.020 |
Why?
|
| Shear Strength | 1 | 2009 | 25 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1991 | 206 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 272 | 0.020 |
Why?
|
| Protein Binding | 2 | 2003 | 972 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 893 | 0.020 |
Why?
|
| Cross Infection | 1 | 2008 | 38 | 0.020 |
Why?
|
| Mercaptoethanol | 1 | 2006 | 13 | 0.020 |
Why?
|
| Acetabulum | 1 | 2006 | 2 | 0.020 |
Why?
|
| Hip Joint | 1 | 2006 | 13 | 0.020 |
Why?
|
| Radiography | 1 | 2006 | 72 | 0.020 |
Why?
|
| Binding Sites | 2 | 2003 | 651 | 0.020 |
Why?
|
| Femur | 1 | 2006 | 36 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 103 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2006 | 66 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2006 | 51 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2001 | 444 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 2005 | 26 | 0.020 |
Why?
|
| Vaccination | 1 | 2006 | 288 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2001 | 859 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2003 | 61 | 0.010 |
Why?
|
| Neck | 1 | 2003 | 22 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 1046 | 0.010 |
Why?
|
| Head | 1 | 2003 | 27 | 0.010 |
Why?
|
| Plankton | 1 | 2002 | 13 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2003 | 189 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 209 | 0.010 |
Why?
|
| Antibodies | 1 | 2003 | 141 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 191 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 150 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2002 | 142 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2006 | 1418 | 0.010 |
Why?
|
| Cell Communication | 1 | 2002 | 97 | 0.010 |
Why?
|
| Actin-Related Protein 2 | 1 | 2001 | 2 | 0.010 |
Why?
|
| Actin-Related Protein 3 | 1 | 2001 | 2 | 0.010 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2001 | 4 | 0.010 |
Why?
|
| Shigella | 1 | 2001 | 10 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2001 | 59 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 677 | 0.010 |
Why?
|
| Bradykinin | 1 | 2001 | 22 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 50 | 0.010 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2001 | 23 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2001 | 88 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 201 | 0.010 |
Why?
|
| Rabbits | 1 | 2001 | 283 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2006 | 2026 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 252 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 295 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 408 | 0.010 |
Why?
|
| Male | 3 | 2006 | 20025 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 515 | 0.010 |
Why?
|
| Plasma Substitutes | 1 | 1998 | 1 | 0.010 |
Why?
|
| Isotonic Solutions | 1 | 1998 | 2 | 0.010 |
Why?
|
| Cardioplegic Solutions | 1 | 1998 | 2 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1998 | 27 | 0.010 |
Why?
|
| Body Water | 1 | 1998 | 26 | 0.010 |
Why?
|
| United States | 1 | 2008 | 4223 | 0.010 |
Why?
|
| Middle Aged | 2 | 2003 | 10129 | 0.010 |
Why?
|
| Hydroxyapatites | 1 | 1991 | 3 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1991 | 8 | 0.010 |
Why?
|
| Diglycerides | 1 | 1991 | 10 | 0.010 |
Why?
|
| Chromatography | 1 | 1991 | 16 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1991 | 41 | 0.010 |
Why?
|
| Durapatite | 1 | 1991 | 17 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1991 | 167 | 0.010 |
Why?
|
| Bis-Trimethylammonium Compounds | 1 | 1950 | 1 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 1950 | 52 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1991 | 161 | 0.010 |
Why?
|
| Mammals | 1 | 1991 | 105 | 0.010 |
Why?
|
| Kinetics | 1 | 1991 | 708 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1991 | 928 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1950 | 646 | 0.000 |
Why?
|
| Hypertension | 1 | 1950 | 796 | 0.000 |
Why?
|